Abstract

The microvasculature plays a critical role in human physiology and is closely associated to various human diseases. By combining advanced microfluidic-based techniques, the engineered 3D microvascular network model provides a precise and reproducible platform to study the microvasculature in vitro, which is an essential and primary component to engineer organ-on-chips and achieve greater biological relevance. In this review, we discuss current strategies to engineer microvessels in vitro, which can be broadly classified into endothelial cell lining-based methods, vasculogenesis and angiogenesis-based methods, and hybrid methods. By closely simulating relevant factors found in vivo such as biomechanical, biochemical, and biological microenvironment, it is possible to create more accurate organ-specific models, including both healthy and pathological vascularized microtissue with their respective vascular barrier properties. We further discuss the integration of tumor cells/spheroids into the engineered microvascular to model the vascularized microtumor tissue, and their potential application in the study of cancer metastasis and anti-cancer drug screening. Finally, we conclude with our commentaries on current progress and future perspective of on-chip vascularization techniques for fundamental and clinical/translational research.

Highlights

  • The circulatory system plays a vital role to maintain homeostasis in the human body

  • Several in vitro studies have been performed to study tumor angiogenesis by co-culturing cancer cells and endothelial cells (ECs) in microfluidic devices. It is normally performed by establishing a vertical 2D endothelial monolayers on the side walls, which can facilitate the better imaging of angiogenic sprouting into the 3D extracellular matrix (ECM) on the axial plane

  • We have provided an overview of different vascularization strategies based on microfluidic technology

Read more

Summary

Introduction

The circulatory system plays a vital role to maintain homeostasis in the human body. It comprises a closed network of arteries, veins, and capillaries that allow blood to circulate throughout the body, for waste product removal, and for gas exchange and nutrient transportation, all of which are essential for organ viability. Microfluidic technologies have emerged as useful tools for the development of organ-on-a-chip, which can offer precise control over various aspects of the cellular microenvironment such as a different profile of fluid flow, gradient of various growth factors, and mechanical properties of versatile biomaterials. All these advantages can facilitate the formation of biomimicking in vitro vascularized microtissue models. We review the current, state-of-the-art in vitro vascularized tumor-on-a-chip models in various disease stages, and their potential applications for anti-cancer drug screening. This review will provide a better understanding of the vascularization process for organ-on-a-chip systems and its applications in cancer biology

In Vitro Vascularization Strategies
EC Lining-Based Methods
Microneedle-Based Removable Method
Micropatterned Planar Hydrogel Slab Bonding Method
Dissolvable Materials-Based Sacrificial Micromolding Method
EC Lining inside a PDMS-Based Microfluidic Channel
Vasculogenesis and Angiogenesis-Based Methods
Angiogenesis
Vascular Inducing Factors
Biomechanical Factors
Cell Source and Cell-Cell Interaction
Selective Vascular Barrier
Application of Engineered Microvascular Networks to Cancer Biology
Tumor Angiogenesis
Tumor Intravasation
Tumor Extravasation
Tumor Microenvironment
Application of Vascularized Tumor-on-a-Chip
Findings
Conclusions and Future Perspectives
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.